{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:09:15Z","timestamp":1790467755200,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,10,13]],"date-time":"2013-10-13T00:00:00Z","timestamp":1381622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11886-013-0425-8","type":"journal-article","created":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T07:26:34Z","timestamp":1381562794000},"source":"Crossref","is-referenced-by-count":35,"title":["Cerebral Microbleeds and Macrobleeds: Should They Influence Our Recommendations for Antithrombotic Therapies?"],"prefix":"10.1007","volume":"15","author":[{"given":"Kellen E.","family":"Haley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Edip","family":"Gurol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,13]]},"reference":[{"key":"425_CR1","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1212\/WNL.41.12.1881","volume":"41","author":"AR Massaro","year":"1991","unstructured":"Massaro AR, Sacco RL, Mohr JP, et al. Clinical discriminators of lobar and deep hemorrhages: the Stroke Data Bank. Neurology. 1991;41:1881\u20135.","journal-title":"Neurology"},{"key":"425_CR2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s11883-008-0050-y","volume":"10","author":"ME Gurol","year":"2008","unstructured":"Gurol ME, Greenberg SM. Management of intracerebral hemorrhage. Curr Atheroscler Rep. 2008;10:324\u201331.","journal-title":"Curr Atheroscler Rep"},{"key":"425_CR3","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1161\/STROKEAHA.109.548974","volume":"40","author":"SM Greenberg","year":"2009","unstructured":"Greenberg SM, Nandigam RN, Delgado P, et al. Microbleeds vs macrobleeds: evidence for distinct entities. Stroke. 2009;40:2382\u20136.","journal-title":"Stroke"},{"key":"425_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","volume":"9","author":"CJJ Asch van","year":"2010","unstructured":"\u2022\u2022 van Asch CJJ, Luitse MJA, Rinkel GE, van der Tweel I, Algra A, Klijn CJM. Incidence, case fatality, and functional outcome of intracerebral haemorrhage overtime, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167\u201376. Recent good quality systematic review of ICH epidemiology and prognosis.","journal-title":"Lancet Neurol"},{"key":"425_CR5","unstructured":"Russell MW, Boulanger L, Joshi AV, Neumann PJ, Menzin J. The economic burden of intracerebral hemorrhage: evidence from managed care. Manag Care Interface. 2006;19:24\u20138, 34."},{"key":"425_CR6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857\u201367.","journal-title":"Ann Intern Med"},{"key":"425_CR7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1212\/01.wnl.0000250340.05202.8b","volume":"68","author":"ML Flaherty","year":"2007","unstructured":"Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68:116\u201321.","journal-title":"Neurology"},{"key":"425_CR8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinte.164.8.880","volume":"164","author":"J Rosand","year":"2004","unstructured":"Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004;164:880\u20134.","journal-title":"Arch Intern Med"},{"key":"425_CR9","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/01.WNL.0000138428.40673.83","volume":"63","author":"JJ Flibotte","year":"2004","unstructured":"Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059\u201364.","journal-title":"Neurology"},{"key":"425_CR10","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/WNL.46.6.1751","volume":"46","author":"SM Greenberg","year":"1996","unstructured":"Greenberg SM, Finklestein SP, Schaefer PW. Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI. Neurology. 1996;46:1751\u20134.","journal-title":"Neurology"},{"key":"425_CR11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00415-008-0967-7","volume":"255","author":"YO Soo","year":"2008","unstructured":"Soo YO, Yang SR, Lam WW, et al. Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol. 2008;255:1679\u201386.","journal-title":"J Neurol"},{"issue":"10 Suppl","key":"425_CR12","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1161\/STROKEAHA.110.595181","volume":"41","author":"MM Poels","year":"2010","unstructured":"Poels MM, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke. 2010;41(10 Suppl):S103\u20136.","journal-title":"Stroke"},{"key":"425_CR13","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1161\/STROKEAHA.109.572594","volume":"41","author":"CE Lovelock","year":"2010","unstructured":"Lovelock CE, Cordonnier C, Naka H, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke. 2010;41:1222\u20138.","journal-title":"Stroke"},{"key":"425_CR14","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/01.STR.0000078311.18928.16","volume":"34","author":"MH Eckman","year":"2003","unstructured":"Eckman MH, Rosand J, Knudsen KA, Singer DE, Greenberg SM. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke. 2003;34:1710\u20136.","journal-title":"Stroke"},{"key":"425_CR15","first-page":"1","volume":"15","author":"ME Gurol","year":"2009","unstructured":"Gurol ME. Cerebral amyloid angiopathy. Turk J Neurol. 2009;15:1\u20139.","journal-title":"Turk J Neurol"},{"key":"425_CR16","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1212\/01.wnl.0000327887.64299.a4","volume":"71","author":"EE Smith","year":"2008","unstructured":"Smith EE, Vijayappa M, Lima F, et al. Impaired visual evoked flow velocity response in cerebral amyloid angiopathy. Neurology. 2008;71:1424\u201330.","journal-title":"Neurology"},{"key":"425_CR17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ana.23830","volume":"73","author":"ME Gurol","year":"2013","unstructured":"Gurol ME, Viswanathan A, Gidicsin C, et al. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography\/magnetic resonance imaging study. Ann Neurol. 2013;73:529\u201336.","journal-title":"Ann Neurol"},{"key":"425_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2377-9-3","volume":"9","author":"HA Keage","year":"2009","unstructured":"Keage HA, Carare RO, Friedland RP, et al. Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol. 2009;9:3.","journal-title":"BMC Neurol"},{"key":"425_CR19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.22112","volume":"69","author":"Z Arvanitakis","year":"2011","unstructured":"Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol. 2011;69:320\u20137.","journal-title":"Ann Neurol"},{"key":"425_CR20","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/01.STR.0000126807.69758.0e","volume":"35","author":"SM Greenberg","year":"2004","unstructured":"Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke. 2004;35:1415\u201320.","journal-title":"Stroke"},{"key":"425_CR21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.56.4.537","volume":"56","author":"KA Knudsen","year":"2001","unstructured":"Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56:537\u20139.","journal-title":"Neurology"},{"key":"425_CR22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11883-003-0048-4","volume":"5","author":"EE Smith","year":"2003","unstructured":"Smith EE, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Curr Atheroscler Rep. 2003;5:260\u20136.","journal-title":"Curr Atheroscler Rep"},{"key":"425_CR23","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad605","volume":"74","author":"J Linn","year":"2010","unstructured":"Linn J, Halpin A, Demaerel P, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology. 2010;74:1346\u201350.","journal-title":"Neurology"},{"key":"425_CR24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/jnnp.2004.044347","volume":"76","author":"M Castellanos","year":"2005","unstructured":"Castellanos M, Leira R, Tejada J, Gil-Peralta A, Davalos A, Castillo J. Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J Neurol Neurosurg Psychiatry. 2005;76:691\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"425_CR25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1212\/WNL.55.7.947","volume":"55","author":"J Rosand","year":"2000","unstructured":"Rosand J, Hylek EM, O'Donnell HC, Greenberg SM. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology. 2000;55:947\u201351.","journal-title":"Neurology"},{"key":"425_CR26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/STROKEAHA.109.563932","volume":"41","author":"H Arima","year":"2010","unstructured":"Arima H, Tzourio C, Anderson C, et al. Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke. 2010;41:394\u20136.","journal-title":"Stroke"},{"key":"425_CR27","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.STR.27.11.2020","volume":"27","author":"AG Thrift","year":"1996","unstructured":"Thrift AG, McNeil JJ, Forbes A, Donnan GA. Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group. Stroke. 1996;27:2020\u20135.","journal-title":"Stroke"},{"key":"425_CR28","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","volume":"127","author":"AS Go","year":"2013","unstructured":"Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics\u20132013 update: a report from the American Heart Association. Circulation. 2013;127:e6\u2013e245.","journal-title":"Circulation"},{"key":"425_CR29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9343(89)80689-8","volume":"87","author":"CS Landefeld","year":"1989","unstructured":"Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989;87:144\u201352.","journal-title":"Am J Med"},{"key":"425_CR30","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1212\/WNL.53.6.1319","volume":"53","author":"JW Gorter","year":"1999","unstructured":"Gorter JW. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology. 1999;53:1319\u201327.","journal-title":"Neurology"},{"key":"425_CR31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1212\/WNL.59.2.193","volume":"59","author":"EE Smith","year":"2002","unstructured":"Smith EE, Rosand J, Knudsen KA, Hylek EM, Greenberg SM. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology. 2002;59:193\u20137.","journal-title":"Neurology"},{"key":"425_CR32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/WNL.0b013e3181eee40f","volume":"75","author":"A Biffi","year":"2010","unstructured":"Biffi A, Halpin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75:693\u20138.","journal-title":"Neurology"},{"key":"425_CR33","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran vs warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139\u201351.","journal-title":"N Engl J Med"},{"key":"425_CR34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban vs warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883\u201391.","journal-title":"N Engl J Med"},{"key":"425_CR35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al. Apixaban vs warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981\u201392.","journal-title":"N Engl J Med"},{"key":"425_CR36","doi-asserted-by":"crossref","unstructured":"\u2022 Lubitz SA, Bauer KA, Benjamin EJ, et al. Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation. A summary of an American Federation of Aging Research Seminar. J Am Geriatr Soc. 2013. doi: 10.1111\/jgs.12456 . Good overview of both established and emerging stroke prevention strategies in patients with atrial fibrillation.","DOI":"10.1111\/jgs.12456"},{"key":"425_CR37","doi-asserted-by":"crossref","unstructured":"Reddy VY, Mobius-Winkler S, Miller MA, et al. Left atrial appendage closure with the Watchman Device in patients with a contraindication for oral anticoagulation: ASA Plavix Feasibility Study with Watchman Left Atrial Appendage Closure Technology (ASAP Study). J Am Coll Cardiol. 2013;61(25):2551\u20136.","DOI":"10.1016\/j.jacc.2013.03.035"},{"key":"425_CR38","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.amjcard.2012.11.061","volume":"111","author":"A Massumi","year":"2013","unstructured":"Massumi A, Chelu MG, Nazeri A, et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol. 2013;111:869\u201373.","journal-title":"Am J Cardiol"},{"key":"425_CR39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/01.wnl.0000194267.09060.77","volume":"66","author":"A Viswanathan","year":"2006","unstructured":"Viswanathan A, Rakich SM, Engel C, et al. Antiplatelet use after intracerebral hemorrhage. Neurology. 2006;66:206\u20139.","journal-title":"Neurology"},{"key":"425_CR40","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/01.STR.26.9.1558","volume":"26","author":"S Juvela","year":"1995","unstructured":"Juvela S, Hillbom M, Palom\u00e4ki H. Risk factors for spontaneous intracerebral hemorrhage. Stroke. 1995;26:1558\u201364.","journal-title":"Stroke"},{"key":"425_CR41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11883-012-0257-9","volume":"14","author":"BE Zacharia","year":"2012","unstructured":"Zacharia BE, Vaughan KA, Jacoby A, Hickman ZL, Bodmer D, Connolly ES. Management of ruptured brain arteriovenous malformations. Curr Atheroscler Rep. 2012;14:335\u201342.","journal-title":"Curr Atheroscler Rep"},{"key":"425_CR42","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s00415-003-0142-0","volume":"250","author":"KA Jellinger","year":"2003","unstructured":"Jellinger KA, Mitter-Ferstl E. The impact of cerebrovascular lesions in Alzheimer disease\u2013a comparative autopsy study. J Neurol. 2003;250:1050\u20135.","journal-title":"J Neurol"},{"key":"425_CR43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","volume":"8","author":"SM Greenberg","year":"2009","unstructured":"Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165\u201374.","journal-title":"Lancet Neurol"},{"key":"425_CR44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1212\/01.WNL.0000101463.50798.0D","volume":"62","author":"SH Lee","year":"2004","unstructured":"Lee SH, Bae HJ, Kwon SJ, et al. Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology. 2004;62:72\u20136.","journal-title":"Neurology"},{"key":"425_CR45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1212\/01.wnl.0000339060.11702.dd","volume":"72","author":"SH Lee","year":"2009","unstructured":"Lee SH, Ryu WS, Roh JK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology. 2009;72:171\u20136.","journal-title":"Neurology"},{"key":"425_CR46","doi-asserted-by":"crossref","unstructured":"van Etten ES, Auriel E, Haley KE, McNamara KA, Ayres AM, Vashkevich A, et al. Warfarin increases risk of future intracerebral hemorrhage in patients presenting with isolated lobar microbleeds on MRI. Stroke 2013;44: Abstract TP301.","DOI":"10.1161\/str.44.suppl_1.ATP301"},{"key":"425_CR47","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/WNL.0b013e3182452928","volume":"78","author":"MM Poels","year":"2012","unstructured":"Poels MM, Ikram MA, van der Lugt A, et al. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology. 2012;78:326\u201333.","journal-title":"Neurology"},{"key":"425_CR48","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/STROKEAHA.110.579078","volume":"41","author":"EE Smith","year":"2010","unstructured":"Smith EE, Nandigam KR, Chen YW, et al. MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke. 2010;41:1933\u20138.","journal-title":"Stroke"},{"key":"425_CR49","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/STROKEAHA.107.497438","volume":"39","author":"CM Holland","year":"2008","unstructured":"Holland CM, Smith EE, Csapo I, et al. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke. 2008;39:1127\u201333.","journal-title":"Stroke"},{"key":"425_CR50","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1212\/01.WNL.0000142966.22886.20","volume":"63","author":"EE Smith","year":"2004","unstructured":"Smith EE, Gurol ME, Eng JA, et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology. 2004;63:1606\u201312.","journal-title":"Neurology"},{"key":"425_CR51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1212\/01.wnl.0000223613.57229.24","volume":"67","author":"YW Chen","year":"2006","unstructured":"Chen YW, Gurol ME, Rosand J, et al. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology. 2006;67:83\u20137.","journal-title":"Neurology"},{"key":"425_CR52","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.neuroimage.2012.01.106","volume":"60","author":"E Rostrup","year":"2012","unstructured":"Rostrup E, Gouw AA, Vrenken H, et al. The spatial distribution of age-related white matter changes as a function of vascular risk factors\u2014results from the LADIS study. Neuroimage. 2012;60:1597\u2013607.","journal-title":"Neuroimage"},{"key":"425_CR53","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00415-012-6610-7","volume":"260","author":"J Linn","year":"2013","unstructured":"Linn J, Wollenweber FA, Lummel N, et al. Superficial siderosis is a warning sign for future intracranial hemorrhage. J Neurol. 2013;260:176\u201381.","journal-title":"J Neurol"},{"key":"425_CR54","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1161\/STROKEAHA.112.657759","volume":"43","author":"A Charidimou","year":"2012","unstructured":"\u2022\u2022 Charidimou A, Peeters A, Fox Z, et al. Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multi-center magnetic resonance imaging cohort study and meta-analysis. Stroke. 2012;43:2324\u201330. A nice review of transient focal deficits in CAA patients including their correlations with imaging findings and prognostic significance.","journal-title":"Stroke"},{"key":"425_CR55","first-page":"745430","volume":"2012","author":"RD Barreto","year":"2012","unstructured":"Barreto RD, Ruano L, Cruz VT, Veira C, Coutinho P. Superficial siderosis and anticoagulation therapy: different presentations, different outcomes. Case Rep Neurol Med. 2012;2012:745430.","journal-title":"Case Rep Neurol Med"},{"key":"425_CR56","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.STR.27.8.1333","volume":"27","author":"SM Greenberg","year":"1996","unstructured":"Greenberg SM, Briggs ME, Hyman BT, et al. Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke. 1996;27:1333\u20137.","journal-title":"Stroke"},{"key":"425_CR57","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.50.4.961","volume":"50","author":"SM Greenberg","year":"1998","unstructured":"Greenberg SM, Vonsattel JP, Segal AZ, et al. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology. 1998;50:961\u20135.","journal-title":"Neurology"},{"key":"425_CR58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJM200001273420403","volume":"342","author":"HC O'Donnell","year":"2000","unstructured":"O'Donnell HC, Rosand J, Knudsen KA, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med. 2000;342:240\u20135.","journal-title":"N Engl J Med"},{"key":"425_CR59","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ana.22134","volume":"68","author":"A Biffi","year":"2010","unstructured":"Biffi A, Sonni A, Anderson CD, et al. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol. 2010;68:934\u201343.","journal-title":"Ann Neurol"},{"key":"425_CR60","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1161\/STROKEAHA.108.523159","volume":"39","author":"MH Eckman","year":"2008","unstructured":"Eckman MH, Wong LK, Soo YO, et al. Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help? Stroke. 2008;39:3308\u201315.","journal-title":"Stroke"},{"key":"425_CR61","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.21164","volume":"62","author":"KA Johnson","year":"2007","unstructured":"Johnson KA, Gregas M, Becker JA, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol. 2007;62:229\u201334.","journal-title":"Ann Neurol"},{"key":"425_CR62","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.21528","volume":"64","author":"SM Greenberg","year":"2008","unstructured":"Greenberg SM, Grabowski T, Gurol ME, et al. Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol. 2008;64:587\u201391.","journal-title":"Ann Neurol"},{"key":"425_CR63","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1212\/WNL.0b013e31826043a9","volume":"79","author":"ME Gurol","year":"2012","unstructured":"\u2022\u2022 Gurol ME, Dierksen G, Betensky R, et al. Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology. 2012;79:320\u20136. Longitudinal study that suggests a potential role of amyloid imaging to predict risk of future ICH in CAA patients.","journal-title":"Neurology"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-013-0425-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-013-0425-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-013-0425-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:24:11Z","timestamp":1646785451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-013-0425-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,13]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1007\/s11886-013-0425-8","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,13]]},"article-number":"425"}}